 |
|
|
|
|
|
NEWS RELEASE:
FOR IMMEDIATE RELEASE:
|
Beth Frost-Johnson, Sr. VP of Marketing
Merge Healthcare
414.977.4254
bethfj@merge.com
|
|
Kenneth D. Rardin
President and CEO
Merge Healthcare
414.977.4000
ir@merge.com
|
|
Merge Healthcare Announces Hiring of New Chief Financial Officer
Milwaukee, WI, January 9, 2007 - Merge Technologies Incorporated, d.b.a. Merge Healthcare (NASDAQ: MRGE; TSX: MRG), today announced that Steven R. Norton has joined the Company as Chief Financial Officer (CFO), reporting directly to Kenneth D. Rardin, President and CEO of Merge Healthcare, effective January 8, 2007. Norton will lead all financial areas of the Company, as well as human resources, legal and investor relations.
"We are thrilled to have an executive with Steve's experience and skill set joining Merge Healthcare's senior team," said Ken Rardin, President and CEO of Merge Healthcare. "We are at a very exciting time in the company's history and Steve’s prior experience in driving operational efficiencies will prove invaluable. Further, as Merge Healthcare expands its sales and global delivery model throughout Europe and Asia, we expect to leverage Steve’s prior international experiences."
Previously, Norton was Senior Vice President and Chief Financial Officer at Manhattan Associates (NASDAQ: MANH), a $300 million leader in supply chain management software and systems, with offices in the United States, Europe, Asia (including a development center with over 500 employees in Bangalore India), and Australia. While at Manhattan, he was responsible for all financial areas, information technology, and investor relations. Prior to that, he spent over five years as an Executive Vice President and Chief Financial Officer with Concurrent Computer Corporation, where his responsibilities included finance, human resources, information technology, investor relations, and manufacturing operations. Additionally, Norton has held senior management positions at LHS Group, Ernst & Young, and KPMG. He received his Bachelor of Arts degree from Michigan State University in 1983.
"Ken and his team at Merge Healthcare have established a strong foundation to position the business for future growth. I am especially pleased to be joining Merge Healthcare at this stage of the Company’s life cycle, allowing me the opportunity to help transform the company and contribute to the growth of the Company as a world-class medical imaging software solutions provider," added Norton.
# # #
Merge Healthcare is a market leader in the development and delivery of medical imaging and information management software and services. Our innovative software solutions use leading-edge imaging software technologies that accelerate market delivery for our OEM customers, while our end-user solutions improve our customers' productivity and enhance the quality of patient care they provide. For additional information, visit our website at www.merge.com.
|
Attn: Beth Frost-Johnson
Merge Healthcare
6737 West Washington St.
Suite 2250
Milwaukee, WI 53214
|
|
|
|
|
|
| Except for the historical information herein, the matters discussed in this news release include forward-looking statements that may involve a number of risks and uncertainties. When used in this press release, the words “will,” “believes,” “intends,” “anticipates,” “expects” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied by, the forward-looking statements based on a number of factors, including, but not limited to, the uncertainty created by, the adverse impact on relationships with customers, potential customers, suppliers and investors potentially resulting from, and other risks associated with, the changes in the Company’s senior management; costs, risks and effects of the investigation by the Audit Committee of the Board of Directors; the impact of the restatement of financial statements of the Company and other actions that may be taken or required as a result of such restatement; the Company's inability to timely file reports with the Securities and Exchange Commission; risks associated with the Company's inability to meet the requirements of The NASDAQ Stock Market for continued listing, including possible delisting; costs, risks and effects of legal proceedings and investigations, including the informal, non-public inquiry being conducted by the Securities and Exchange Commission and class action, derivative, and other lawsuits; risks in product and technology development, market acceptance of new products and continuing product demand, the impact of competitive products and pricing, ability to integrate acquisitions, changing economic conditions, credit and payment risks associated with end-user sales, dependence on major customers, dependence on key personnel, and other risk factors detailed in the Company’s filings with the Securities and Exchange Commission. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements contained herein to reflect future events, developments, or changed circumstances, or for any other reason.
|
|
|
